Clinical Outcomes and Bacterial Characteristics of Carbapenem-Resistant Acinetobacter baumannii Among Patients from Different Global Regions
Minggui Wang,Lizhao Ge,Liang Chen,Lauren Komarow,Blake Hanson,Jinnethe Reyes,Eric Cober,Thamer Alenazi,Zhiyong Zong,Qing Xie,Zhengyin Liu,Lanjuan Li,Yunsong Yu,Hainv Gao,Souha S Kanj,Jairo Figueroa,Erica Herc,Ezequiel Cordova,Gregory Weston,Paul Ananth Tambyah,Julia Garcia-Diaz,Keith S Kaye,Sorabh Dhar,Jose M Munita,Robert A Salata,Samuel Vilchez,Martin E Stryjewski,Maria Virginia Villegas Botero,Alina Iovleva,Scott Evans,Keri Baum,Carol Hill,Barry N Kreiswirth,Robin Patel,David L Paterson,Cesar A Arias,Robert A Bonomo,Henry F Chambers,Vance G Fowler,Michael J Satlin,David van Duin,Yohei Doi,Souha S Kanj,Fujie Zhang,Judith J Lok,Robert A Salata,Martin Stryjewski,Valentina Di Castelnuovo,Jose Millan Oñate Gutierrez,Eric Cober,Susan Richter,Deverick J Anderson,Beth Evans,Carol Hill,Heather R Cross,Keri Baum,Rebekka Arias,Vance G Fowler,Karen Ordoñez,Jesse T Jacob,Linghua Li,Barry N Kreiswirth,Claudia Manca,Liang Chen,Samit Desai,Erica Herc,Ezequiel Cordova,Maria Rioseco,Samuel Vilchez,Marisa L Sanchez,Sandra Valderrama,Jairo Figueroa,Cesar A Arias,An Q Dinh,Diane Panesso,Kirsten Rydell,Truc T Tran,Fupin Hu,Jiachun Su,Jianping Jiang,Minggui Wang,Xiaogang Xu,Yang Yang,Jose M Munita,Maria Spencer,Thamer Alenazi,Robert A Bonomo,Steven H Marshall,Susan D Rudin,Charles Huskins,Kerry Greenwood-Quaintance,Robin Patel,Suzannah Schmidt-Malan,Sara Revolinski,Glenn Wortmann,Robert C Kalayjian,Gregory Weston,Belinda Ostrowsky,Gopi Patel,Daniel Eiras,Angela Kim,Julia Garcia-Diaz,Soraya Salcedo,John J Farrell,Zhengyin Liu,Andrew Henderson,David L Paterson,Qing Xie,Keith S Kaye,Hainv Gao,Yunsong Yu,Mary Waters,Bettina C Fries,Brandon Eilertson,Kalisvar Marimuthu,Oon Tek Ng,Partha Pratim De,Kean Lee Chew,Nares Smitasin,Paul Ananth Tambyah,Jason C Gallagher,Anton Peleg,Marcel Leroi,Lanjuan Li,Yonghong Xiao,Lauren Komarow,Lizhao Ge,Scott Evans,Todd McCarty,Henry F Chambers,Omai B Garner,Lilian M Abbo,David van Duin,Ebbing Lautenbach,Jennifer H Han,Yohei Doi,Darren Wong,Blake Hanson,Jinnethe Reyes,Maria Virginia Villegas Botero,Lorena Diaz,Federico Perez,Ritu Banerjee,Sorabh Dhar,Michael J Satlin,Lars F Westblade,Zhiyong Zong,Multi-Drug Resistant Organism Network Investigators
DOI: https://doi.org/10.1093/cid/ciad556
IF: 20.999
2023-09-24
Clinical Infectious Diseases
Abstract:Carbapenem-resistant Acinetobacter baumannii (CRAb) is one of the most problematic antimicrobial-resistant bacteria. We sought to elucidate the international epidemiology and clinical impact of CRAb. In a prospective observational cohort study, 842 hospitalized patients with a clinical CRAb culture were enrolled at 46 hospitals in five global regions between 2017 and 2019. The primary outcome was all-cause mortality at 30 days from the index culture. The strains underwent whole-genome analysis. Of 842 cases, 536 (64%) represented infection. By 30 days, 128 (24%) of the infected patients died, ranging from 1 (6%) of 18 in Australia-Singapore to 54 (25%) of 216 in the United States and 24 (49%) of 49 in South-Central America, whereas 42 (14%) of non-infected patients died. Bacteremia was associated with a higher risk of death compared with other types of infection (40 [42%] of 96 vs. 88 [20%] of 440). In a multivariable logistic regression analysis, bloodstream infection and higher age-adjusted Charlson comorbidity index were independently associated with 30-day mortality. Clonal group 2 (CG2) strains predominated except in South-Central America, ranging from 216 (59%) of 369 in the United States to 282 (97%) of 291 in China. Acquired carbapenemase genes were carried by 769 (91%) of the 842 isolates. CG2 strains were significantly associated with higher levels of meropenem resistance, yet non-CG2 cases were over-represented among the deaths compared with CG2 cases. CRAb infection types and clinical outcomes differed significantly across regions. While CG2 strains remained predominant, non-CG2 strains were associated with higher mortality. #NCT03646227
immunology,infectious diseases,microbiology